共 8 条
[1]
Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaem ic brain syndromes: setting a new standard of care. Hankey G. Cerebrovascular Diseases . 2004
[2]
D ipyridamole for preventing recurrent ischem ic stroke and other vascular events: A meta-analysis of individual patient data from random ized controlled trials. Leonardi-Bee J,Bath PM,Bousser MG,et al. Stroke . 2005
[3]
Collaborative overview of random ised trials of antiplatelet therapy.I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists ’ Collaboration. British Medical Journal . 1994
[4]
Collaborativemeta-analysis of random ised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists ’ Collaboration. British Medical Journal . 2002
[5]
Indications for early asp irin use in acute ischem ic stroke : A combined analysis of 40 000 random ized patients from the chinese acute stroke trial and the international stroke trial.On behalf of the CAST and IST collaborative groups. Chen ZM,Sandercock P,Pan HC,et al. Stroke . 2000
[6]
European stroke prevention study 2.D ipyridamole and acetylsalicylic acid in the secondary prevention of stroke. D ienerH,Cunha L,Forbes C,et al. Journal of the Neurological Sciences . 1996
[7]
A random ized trial of lowdose asp irin in the primary prevention of cardiovascular disease in women. R idker PM,Cook NR,Lee IM,et al. The New England Journal of Medicine . 2005
[8]
A random ised, blinded,trial of clop idogrel versus asp irin in patients at risk of ischaem ic events ( CAPR IE ).CAPR IE Steering Comm ittee. GentM,Beaumont D,B lanchard J,et al. The Lancet . 1996